Investing
Proceeds from Sale of Seagen Inc. Common Stock
Walmart Proceeds from Sale of Seagen Inc. Common Stock remained flat by 0.0% to $231.75M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 92.9%, from $3.28B to $231.75M.
Analysis
StatementCash Flow Statement
SectionInvesting
First reportedQ4 2023
Last reportedQ4 2026Mar 13, 2026
Metric ID:
mrk_proceeds_from_sale_of_seagen_stockHistorical Data
9 periods
| Q4 '23 | Q3 '24 | Q4 '24 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $3.66B | -$3.81B | $24.00M | $3.28B | $231.75M | $231.75M | $231.75M | $231.75M |
| QoQ Change | — | — | -204.1% | +100.6% | >999% | -92.9% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | -99.3% | +186.0% | — | — | +865.6% | -92.9% |
Range-$3.81B – $3.66B
Avg YoY Growth+214.8%
Median YoY Growth+46.6%
Current Streak3 quarters growth
Proceeds from Sale of Seagen Inc. Common Stock at Other Companies
Frequently Asked Questions
- What is Walmart 's proceeds from sale of seagen inc. common stock?
- Walmart (WMT) reported proceeds from sale of seagen inc. common stock of $231.75M in Q4 2025.
- How has Walmart 's proceeds from sale of seagen inc. common stock changed year-over-year?
- Walmart 's proceeds from sale of seagen inc. common stock decreased by 92.9% year-over-year, from $3.28B to $231.75M.